Literature DB >> 6496047

Analysis of intrapartum fetal deaths: their decline with increasing electronic fetal monitoring.

R Erkkola, M Grönroos, R Punnonen, P Kilkku.   

Abstract

Over a 12-year period, from 1970 to 1981, 30 600 babies were born at the Department of Obstetrics and Gynecology, University Central Hospital, Turku, Finland. During that period, the use of electronic fetal monitoring increased remarkably, being involved in 9, 12, 33 and 95% of all vaginal deliveries during four consecutive 3-year periods. The number of intrapartum deaths during the same 12-year period was 52, giving an overall rate of 1.7 per thousand. When 15 lethally malformed infants are excluded, the rate becomes 1.2 per thousand. In the four consecutive 3-year periods, the death rates were 1.7, 1.9, 1.0 and 0.3 per thousand. Electronic fetal monitoring was not undertaken in any of the cases leading to fetal death. The main factor leading to fetal death could be considered to be hypoxia in approximately 90% of the deaths of normally formed babies. The most common reasons for hypoxia were placental abruption and cord entanglement, yet in many cases only the decreased placental perfusion could be suggested to have caused the hypoxia. The mean weight of those babies that died intrapartally decreased significantly, being approximately 1 250 g during the last 3-year period.

Entities:  

Mesh:

Year:  1984        PMID: 6496047     DOI: 10.3109/00016348409156703

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  3 in total

1.  Deaths related to intrapartum asphyxia.

Authors:  J A Spencer
Journal:  BMJ       Date:  1998-02-28

2.  Declining perinatal mortality in a region of Finland, 1968-82.

Authors:  P Piekkala; R Erkkola; P Kero; A Tenovuo; M Sillanpää
Journal:  Am J Public Health       Date:  1985-02       Impact factor: 9.308

3.  Fetal and neonatal mortality of small-for-gestational age infants. A 15-year study of 381 cases.

Authors:  A Tenovuo; P Kero; P Piekkala; H Korvenranta; R Erkkola
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.